Symbol:
CTTNBP2NL
Name:
CTTNBP2 N-terminal like
RGD ID:
1607020
HGNC Page
HGNC:25330
Description:
Enables protein phosphatase 2A binding activity. Acts upstream of or within negative regulation of transmembrane transport; negative regulation of transporter activity; and protein dephosphorylation. Located in actin cytoskeleton. Part of FAR/SIN/STRIPAK complex.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
CTTNBP2 N-terminal-like protein; DKFZp547A023; FLJ13278
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Mus musculus (house mouse):
Cttnbp2nl (CTTNBP2 N-terminal like)
HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):
Cttnbp2nl (CTTNBP2 N-terminal like)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Chinchilla lanigera (long-tailed chinchilla):
Cttnbp2nl (CTTNBP2 N-terminal like)
NCBI
Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):
CTTNBP2NL (CTTNBP2 N-terminal like)
NCBI
Ortholog
Canis lupus familiaris (dog):
CTTNBP2NL (CTTNBP2 N-terminal like)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Cttnbp2nl (CTTNBP2 N-terminal like)
NCBI
Ortholog
Sus scrofa (pig):
CTTNBP2NL (CTTNBP2 N-terminal like)
HGNC
EggNOG, Ensembl, Inparanoid, NCBI, OMA, OrthoDB, Panther, Treefam
Chlorocebus sabaeus (green monkey):
CTTNBP2NL (CTTNBP2 N-terminal like)
NCBI
Ortholog
Heterocephalus glaber (naked mole-rat):
Cttnbp2nl (CTTNBP2 N-terminal like)
NCBI
Ortholog
Alliance orthologs 3
Rattus norvegicus (Norway rat):
Cttnbp2nl (CTTNBP2 N-terminal like)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Cttnbp2nl (CTTNBP2 N-terminal like)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Danio rerio (zebrafish):
cttnbp2nlb (CTTNBP2 N-terminal like b)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid|ZFIN)
Danio rerio (zebrafish):
cttnbp2nla (CTTNBP2 N-terminal like a)
Alliance
DIOPT (Ensembl Compara|OMA|OrthoFinder|OrthoInspector|PANTHER|ZFIN)
Drosophila melanogaster (fruit fly):
CG10915
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OrthoInspector|PANTHER|PhylomeDB)
Caenorhabditis elegans (roundworm):
C49H3.6
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OrthoInspector|PANTHER|PhylomeDB)
Xenopus tropicalis (tropical clawed frog):
cttnbp2nl
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus laevis (African clawed frog):
cttnbp2nl.L
Alliance
DIOPT (Xenbase)
Allele / Splice:
See ClinVar data
Latest Assembly:
GRCh38 - Human Genome Assembly GRCh38
Position:
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 1 112,391,087 - 112,461,164 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 1 112,396,214 - 112,463,456 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 1 112,938,836 - 113,003,786 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 1 112,740,383 - 112,803,739 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 1 111,169,369 - 111,234,318 (+) NCBI Celera Cytogenetic Map 1 p13.2 NCBI HuRef 1 110,795,912 - 110,861,154 (+) NCBI HuRef CHM1_1 1 113,053,632 - 113,118,610 (+) NCBI CHM1_1 T2T-CHM13v2.0 1 112,403,339 - 112,473,705 (+) NCBI T2T-CHM13v2.0
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
CTTNBP2NL Human 1,1-dichloroethene increases expression ISO Cttnbp2nl (Mus musculus) 6480464 vinylidene chloride results in increased expression of CTTNBP2NL mRNA CTD PMID:26682919 CTTNBP2NL Human 1,2-dimethylhydrazine multiple interactions ISO Cttnbp2nl (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CTTNBP2NL mRNA CTD PMID:22206623 CTTNBP2NL Human 1,2-dimethylhydrazine decreases expression ISO Cttnbp2nl (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CTTNBP2NL mRNA CTD PMID:22206623 CTTNBP2NL Human 1-naphthyl isothiocyanate increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 1-Naphthylisothiocyanate results in increased expression of CTTNBP2NL mRNA CTD PMID:25380136 CTTNBP2NL Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cttnbp2nl (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CTTNBP2NL mRNA CTD PMID:21570461 CTTNBP2NL Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CTTNBP2NL mRNA CTD PMID:34747641 CTTNBP2NL Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CTTNBP2NL mRNA CTD PMID:28628672 CTTNBP2NL Human 4,4'-diaminodiphenylmethane increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of CTTNBP2NL mRNA CTD PMID:25380136 and PMID:30723492 CTTNBP2NL Human 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CTTNBP2NL mRNA CTD PMID:28628672 CTTNBP2NL Human 4,4'-sulfonyldiphenol decreases expression ISO Cttnbp2nl (Mus musculus) 6480464 bisphenol S results in decreased expression of CTTNBP2NL mRNA CTD PMID:39298647 CTTNBP2NL Human 4-hydroxyphenyl retinamide increases expression ISO Cttnbp2nl (Mus musculus) 6480464 Fenretinide results in increased expression of CTTNBP2NL mRNA CTD PMID:28973697 CTTNBP2NL Human 6-propyl-2-thiouracil increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of CTTNBP2NL mRNA CTD PMID:22504374 more ... CTTNBP2NL Human acetamide increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 acetamide results in increased expression of CTTNBP2NL mRNA CTD PMID:31881176 CTTNBP2NL Human aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of CTTNBP2NL protein CTD PMID:20106945 CTTNBP2NL Human amitrole increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Amitrole results in increased expression of CTTNBP2NL mRNA CTD PMID:30047161 CTTNBP2NL Human arsane decreases expression ISO Cttnbp2nl (Mus musculus) 6480464 Arsenic results in decreased expression of CTTNBP2NL mRNA CTD PMID:19654921 CTTNBP2NL Human arsenic atom decreases expression ISO Cttnbp2nl (Mus musculus) 6480464 Arsenic results in decreased expression of CTTNBP2NL mRNA CTD PMID:19654921 CTTNBP2NL Human arsenite(3-) multiple interactions EXP 6480464 arsenite inhibits the reaction [G3BP1 protein binds to CTTNBP2NL mRNA] CTD PMID:32406909 CTTNBP2NL Human arsenous acid decreases expression ISO Cttnbp2nl (Mus musculus) 6480464 Arsenic Trioxide results in decreased expression of CTTNBP2NL mRNA CTD PMID:29095437 CTTNBP2NL Human arsenous acid multiple interactions ISO Cttnbp2nl (Mus musculus) 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of CTTNBP2NL mRNA] CTD PMID:29095437 CTTNBP2NL Human atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of CTTNBP2NL mRNA CTD PMID:22378314 CTTNBP2NL Human benzo[a]pyrene increases expression ISO Cttnbp2nl (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of CTTNBP2NL mRNA CTD PMID:21569818 and PMID:22228805 CTTNBP2NL Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of CTTNBP2NL intron CTD PMID:30157460 CTTNBP2NL Human benzo[a]pyrene increases methylation ISO Cttnbp2nl (Mus musculus) 6480464 Benzo(a)pyrene results in increased methylation of CTTNBP2NL intron CTD PMID:27901495 CTTNBP2NL Human benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of CTTNBP2NL 5' UTR CTD PMID:27901495 CTTNBP2NL Human benzo[a]pyrene diol epoxide I decreases expression EXP 6480464 7 more ... CTD PMID:19150397 CTTNBP2NL Human Benzo[k]fluoranthene decreases expression ISO Cttnbp2nl (Mus musculus) 6480464 benzo(k)fluoranthene results in decreased expression of CTTNBP2NL mRNA CTD PMID:26377693 CTTNBP2NL Human bisphenol A increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 bisphenol A results in increased expression of CTTNBP2NL mRNA CTD PMID:25181051 more ... CTTNBP2NL Human bisphenol F increases expression ISO Cttnbp2nl (Mus musculus) 6480464 bisphenol F results in increased expression of CTTNBP2NL mRNA CTD PMID:38685157 CTTNBP2NL Human cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CTTNBP2NL mRNA CTD PMID:35301059 CTTNBP2NL Human cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CTTNBP2NL mRNA CTD PMID:35301059 CTTNBP2NL Human caffeine decreases phosphorylation EXP 6480464 Caffeine results in decreased phosphorylation of CTTNBP2NL protein CTD PMID:35688186 CTTNBP2NL Human carbon nanotube increases expression ISO Cttnbp2nl (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of CTTNBP2NL mRNA CTD PMID:25554681 CTTNBP2NL Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to CTTNBP2NL gene] CTD PMID:28238834 CTTNBP2NL Human chloroprene increases expression ISO Cttnbp2nl (Mus musculus) 6480464 Chloroprene results in increased expression of CTTNBP2NL mRNA CTD PMID:23125180 CTTNBP2NL Human chlorpyrifos increases expression ISO Cttnbp2nl (Mus musculus) 6480464 Chlorpyrifos results in increased expression of CTTNBP2NL mRNA CTD PMID:37019170 CTTNBP2NL Human copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of CTTNBP2NL mRNA CTD PMID:19549813 CTTNBP2NL Human coumarin affects phosphorylation EXP 6480464 coumarin affects the phosphorylation of CTTNBP2NL protein CTD PMID:35688186 CTTNBP2NL Human coumestrol multiple interactions EXP 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 CTTNBP2NL Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of CTTNBP2NL mRNA CTD PMID:25562108 CTTNBP2NL Human cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of CTTNBP2NL mRNA CTD PMID:27989131 CTTNBP2NL Human dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CTTNBP2NL mRNA CTD PMID:28628672 CTTNBP2NL Human diarsenic trioxide multiple interactions ISO Cttnbp2nl (Mus musculus) 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of CTTNBP2NL mRNA] CTD PMID:29095437 CTTNBP2NL Human diarsenic trioxide decreases expression ISO Cttnbp2nl (Mus musculus) 6480464 Arsenic Trioxide results in decreased expression of CTTNBP2NL mRNA CTD PMID:29095437 CTTNBP2NL Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTTNBP2NL mRNA CTD PMID:27188386 CTTNBP2NL Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of CTTNBP2NL mRNA CTD PMID:29803840 CTTNBP2NL Human endosulfan decreases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Endosulfan results in decreased expression of CTTNBP2NL mRNA CTD PMID:29391264 CTTNBP2NL Human Enterolactone multiple interactions EXP 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CTTNBP2NL mRNA CTD PMID:19167446 CTTNBP2NL Human ethyl methanesulfonate increases expression EXP 6480464 Ethyl Methanesulfonate results in increased expression of CTTNBP2NL mRNA CTD PMID:23649840 CTTNBP2NL Human fluoranthene multiple interactions ISO Cttnbp2nl (Mus musculus) 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of CTTNBP2NL mRNA CTD PMID:28329830 CTTNBP2NL Human folic acid multiple interactions ISO Cttnbp2nl (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CTTNBP2NL mRNA CTD PMID:22206623 CTTNBP2NL Human formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of CTTNBP2NL mRNA CTD PMID:23649840 CTTNBP2NL Human FR900359 decreases phosphorylation EXP 6480464 FR900359 results in decreased phosphorylation of CTTNBP2NL protein CTD PMID:37730182 CTTNBP2NL Human furan increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 furan results in increased expression of CTTNBP2NL mRNA CTD PMID:27387713 CTTNBP2NL Human gentamycin decreases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of CTTNBP2NL mRNA CTD PMID:33387578 CTTNBP2NL Human indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of CTTNBP2NL mRNA CTD PMID:28628672 CTTNBP2NL Human inulin multiple interactions ISO Cttnbp2nl (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CTTNBP2NL mRNA CTD PMID:36331819 CTTNBP2NL Human ivermectin decreases expression EXP 6480464 Ivermectin results in decreased expression of CTTNBP2NL protein CTD PMID:32959892 CTTNBP2NL Human ketamine decreases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Ketamine results in decreased expression of CTTNBP2NL mRNA CTD PMID:20080153 CTTNBP2NL Human metformin multiple interactions ISO Cttnbp2nl (Mus musculus) 6480464 Metformin inhibits the reaction [Arsenic Trioxide results in decreased expression of CTTNBP2NL mRNA] CTD PMID:29095437 CTTNBP2NL Human methimazole increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Methimazole results in increased expression of CTTNBP2NL mRNA CTD PMID:22504374 and PMID:30047161 CTTNBP2NL Human methyl methanesulfonate increases expression EXP 6480464 Methyl Methanesulfonate results in increased expression of CTTNBP2NL mRNA CTD PMID:23649840 CTTNBP2NL Human methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of CTTNBP2NL mRNA CTD PMID:28001369 CTTNBP2NL Human N-nitrosodimethylamine increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Dimethylnitrosamine results in increased expression of CTTNBP2NL mRNA CTD PMID:25380136 CTTNBP2NL Human oxaliplatin multiple interactions ISO Cttnbp2nl (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CTTNBP2NL mRNA CTD PMID:25729387 CTTNBP2NL Human paracetamol affects expression ISO Cttnbp2nl (Mus musculus) 6480464 Acetaminophen affects the expression of CTTNBP2NL mRNA CTD PMID:17562736 CTTNBP2NL Human perfluorooctane-1-sulfonic acid multiple interactions ISO Cttnbp2nl (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CTTNBP2NL mRNA CTD PMID:36331819 CTTNBP2NL Human pirinixic acid decreases expression ISO Cttnbp2nl (Mus musculus) 6480464 pirinixic acid results in decreased expression of CTTNBP2NL mRNA CTD PMID:20813756 CTTNBP2NL Human potassium dichromate increases expression ISO Cttnbp2nl (Mus musculus) 6480464 Potassium Dichromate results in increased expression of CTTNBP2NL mRNA CTD PMID:23608068 CTTNBP2NL Human resveratrol multiple interactions EXP 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of CTTNBP2NL mRNA CTD PMID:19167446 CTTNBP2NL Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTTNBP2NL mRNA CTD PMID:27188386 CTTNBP2NL Human silicon dioxide increases expression ISO Cttnbp2nl (Mus musculus) 6480464 Silicon Dioxide results in increased expression of CTTNBP2NL mRNA CTD PMID:19073995 and PMID:33720480 CTTNBP2NL Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of CTTNBP2NL mRNA CTD PMID:38568856 CTTNBP2NL Human Soman increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Soman results in increased expression of CTTNBP2NL mRNA CTD PMID:19281266 CTTNBP2NL Human succimer multiple interactions ISO Cttnbp2nl (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CTTNBP2NL mRNA CTD PMID:21641980 CTTNBP2NL Human sulfadimethoxine increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Sulfadimethoxine results in increased expression of CTTNBP2NL mRNA CTD PMID:30047161 CTTNBP2NL Human sulforaphane decreases expression ISO Cttnbp2nl (Mus musculus) 6480464 sulforaphane results in decreased expression of CTTNBP2NL mRNA CTD PMID:30529165 CTTNBP2NL Human sunitinib decreases expression EXP 6480464 Sunitinib results in decreased expression of CTTNBP2NL mRNA CTD PMID:31533062 CTTNBP2NL Human thioacetamide increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of CTTNBP2NL mRNA CTD PMID:34492290 CTTNBP2NL Human titanium dioxide decreases methylation ISO Cttnbp2nl (Mus musculus) 6480464 titanium dioxide results in decreased methylation of CTTNBP2NL gene and titanium dioxide results in decreased methylation of CTTNBP2NL promoter CTD PMID:35295148 CTTNBP2NL Human topotecan multiple interactions ISO Cttnbp2nl (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CTTNBP2NL mRNA CTD PMID:25729387 CTTNBP2NL Human topotecan increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 Topotecan results in increased expression of CTTNBP2NL mRNA CTD PMID:25729387 CTTNBP2NL Human triadimefon increases expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 triadimefon results in increased expression of CTTNBP2NL mRNA CTD PMID:30047161 CTTNBP2NL Human trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of CTTNBP2NL mRNA CTD PMID:24935251 CTTNBP2NL Human trichostatin A affects expression EXP 6480464 trichostatin A affects the expression of CTTNBP2NL mRNA CTD PMID:28542535 CTTNBP2NL Human triptonide increases expression ISO Cttnbp2nl (Mus musculus) 6480464 triptonide results in increased expression of CTTNBP2NL mRNA CTD PMID:33045310 CTTNBP2NL Human trovafloxacin increases expression ISO Cttnbp2nl (Mus musculus) 6480464 trovafloxacin results in increased expression of CTTNBP2NL mRNA CTD PMID:35537566 CTTNBP2NL Human urethane increases expression EXP 6480464 Urethane results in increased expression of CTTNBP2NL mRNA CTD PMID:28818685 CTTNBP2NL Human valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of CTTNBP2NL gene CTD PMID:29154799 CTTNBP2NL Human vancomycin decreases expression ISO Cttnbp2nl (Mus musculus) 6480464 Vancomycin results in decreased expression of CTTNBP2NL mRNA CTD PMID:18930951 CTTNBP2NL Human vinclozolin affects expression ISO Cttnbp2nl (Rattus norvegicus) 6480464 vinclozolin affects the expression of CTTNBP2NL mRNA CTD PMID:19015723 CTTNBP2NL Human vorinostat multiple interactions EXP 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CTTNBP2NL mRNA CTD PMID:27188386
CTTNBP2NL (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 1 112,391,087 - 112,461,164 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 1 112,396,214 - 112,463,456 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 1 112,938,836 - 113,003,786 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 1 112,740,383 - 112,803,739 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 1 111,169,369 - 111,234,318 (+) NCBI Celera Cytogenetic Map 1 p13.2 NCBI HuRef 1 110,795,912 - 110,861,154 (+) NCBI HuRef CHM1_1 1 113,053,632 - 113,118,610 (+) NCBI CHM1_1 T2T-CHM13v2.0 1 112,403,339 - 112,473,705 (+) NCBI T2T-CHM13v2.0
Cttnbp2nl (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 3 104,909,231 - 104,960,462 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 3 104,909,231 - 104,960,462 (-) Ensembl GRCm39 Ensembl GRCm38 3 105,001,915 - 105,053,146 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 3 105,001,915 - 105,053,146 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 3 104,804,833 - 104,856,064 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 3 105,131,801 - 105,181,202 (-) NCBI MGSCv36 mm8 Celera 3 107,199,733 - 107,250,872 (-) NCBI Celera Cytogenetic Map 3 F2.2 NCBI cM Map 3 45.88 NCBI
Cttnbp2nl (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 2 195,196,318 - 195,244,792 (-) NCBI GRCr8 mRatBN7.2 2 192,507,963 - 192,554,548 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 2 192,507,963 - 192,541,101 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 2 200,101,956 - 200,148,586 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 2 197,974,589 - 198,021,168 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 2 192,791,536 - 192,838,115 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 2 207,495,056 - 207,541,808 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 2 207,495,055 - 207,541,645 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 2 226,917,956 - 226,964,542 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 2 200,272,402 - 200,319,448 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 2 200,235,155 - 200,282,193 (-) NCBI Celera 2 184,973,748 - 185,020,236 (-) NCBI Celera Cytogenetic Map 2 q34 NCBI
Cttnbp2nl (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955435 15,857,948 - 15,910,486 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955435 15,858,056 - 15,910,486 (+) NCBI ChiLan1.0 ChiLan1.0
CTTNBP2NL (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 1 114,574,923 - 114,640,338 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 1 113,723,050 - 113,788,449 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 1 115,049,389 - 115,114,146 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 1 125,233,780 - 125,301,107 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 1 125,236,986 - 125,300,860 (-) Ensembl panpan1.1 panPan2
CTTNBP2NL (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 17 63,078,111 - 63,132,251 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 17 63,079,732 - 63,118,653 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 17 62,591,512 - 62,646,041 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 17 64,252,356 - 64,306,962 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 17 64,252,356 - 64,306,001 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 17 62,986,214 - 63,040,734 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 17 63,044,585 - 63,099,107 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 17 63,852,322 - 63,893,840 (-) NCBI UU_Cfam_GSD_1.0
Cttnbp2nl (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405058 16,442,784 - 16,495,365 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936690 982,402 - 1,035,005 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936690 982,414 - 1,034,947 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
CTTNBP2NL (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 4 107,959,571 - 108,011,611 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 4 107,957,420 - 108,012,764 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 4 118,026,554 - 118,082,336 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
CTTNBP2NL (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 20 21,181,241 - 21,248,049 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 20 21,180,925 - 21,247,981 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666038 37,233,367 - 37,300,128 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Cttnbp2nl (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 1637 Count of miRNA genes: 976 Interacting mature miRNAs: 1131 Transcripts: ENST00000271277, ENST00000441739, ENST00000502356, ENST00000607039 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
597492830 GWAS1588904_H COVID-19 QTL GWAS1588904 (human) 0.000007 COVID-19 1 112392939 112392940 Human 1300021 BP45_H Blood pressure QTL 45 (human) 1.77 0.00218 Blood pressure systolic 1 103389009 129389009 Human 597274879 GWAS1370953_H educational attainment QTL GWAS1370953 (human) 8e-09 educational attainment 1 112421990 112421991 Human 597326467 GWAS1422541_H FEV/FVC ratio QTL GWAS1422541 (human) 4e-12 FEV/FVC ratio forced expiratory volume to forced vital capacity ratio (CMO:0000241) 1 112403161 112403162 Human 597061162 GWAS1157236_H FEV/FVC ratio QTL GWAS1157236 (human) 5e-09 FEV/FVC ratio forced expiratory volume to forced vital capacity ratio (CMO:0000241) 1 112403161 112403162 Human 597119130 GWAS1215204_H neutrophil count QTL GWAS1215204 (human) 3e-16 neutrophil quantity (VT:0000222) blood neutrophil count (CMO:0000030) 1 112404281 112404282 Human
SHGC-53201
Human Assembly Chr Position (strand) Source JBrowse GRCh37 1 113,000,728 - 113,000,855 UniSTS GRCh37 Build 36 1 112,802,251 - 112,802,378 RGD NCBI36 Celera 1 111,231,265 - 111,231,392 RGD Cytogenetic Map 1 p13.2 UniSTS HuRef 1 110,858,101 - 110,858,228 UniSTS TNG Radiation Hybrid Map 1 60832.0 UniSTS
D1S2594
Human Assembly Chr Position (strand) Source JBrowse GRCh37 1 113,005,701 - 113,005,915 UniSTS GRCh37 Build 36 1 112,807,224 - 112,807,438 RGD NCBI36 Celera 1 111,236,233 - 111,236,447 RGD Cytogenetic Map 1 p13.2 UniSTS HuRef 1 110,863,069 - 110,863,283 UniSTS Stanford-G3 RH Map 1 5232.0 UniSTS
SHGC-75328
Human Assembly Chr Position (strand) Source JBrowse GRCh37 1 112,962,026 - 112,962,151 UniSTS GRCh37 Build 36 1 112,763,549 - 112,763,674 RGD NCBI36 Celera 1 111,192,582 - 111,192,707 RGD Cytogenetic Map 1 p13.2 UniSTS HuRef 1 110,819,126 - 110,819,251 UniSTS TNG Radiation Hybrid Map 1 60739.0 UniSTS GeneMap99-GB4 RH Map 1 362.04 UniSTS
RH69499
Human Assembly Chr Position (strand) Source JBrowse GRCh37 1 113,002,551 - 113,002,806 UniSTS GRCh37 Build 36 1 112,804,074 - 112,804,329 RGD NCBI36 Celera 1 111,233,083 - 111,233,338 RGD Cytogenetic Map 1 p13.2 UniSTS HuRef 1 110,859,919 - 110,860,174 UniSTS GeneMap99-GB4 RH Map 1 360.32 UniSTS
SHGC-75334
Human Assembly Chr Position (strand) Source JBrowse GRCh37 1 113,001,197 - 113,001,361 UniSTS GRCh37 Build 36 1 112,802,720 - 112,802,884 RGD NCBI36 Celera 1 111,231,730 - 111,231,894 RGD Cytogenetic Map 1 p13.2 UniSTS HuRef 1 110,858,566 - 110,858,730 UniSTS TNG Radiation Hybrid Map 1 60832.0 UniSTS GeneMap99-GB4 RH Map 1 363.97 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
entire extraembryonic component
1204
2438
2788
2252
4974
1726
2351
5
624
1934
465
2270
7289
6455
53
3734
1
852
1744
1617
175
1
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENST00000271277 ⟹ ENSP00000271277
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 1 112,396,214 - 112,461,164 (+) Ensembl
Ensembl Acc Id:
ENST00000441739 ⟹ ENSP00000390976
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 1 112,396,519 - 112,456,306 (+) Ensembl
Ensembl Acc Id:
ENST00000502356
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 1 112,414,717 - 112,416,287 (+) Ensembl
Ensembl Acc Id:
ENST00000607039
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38.p14 Ensembl 1 112,456,818 - 112,463,456 (+) Ensembl
RefSeq Acc Id:
NM_018704 ⟹ NP_061174
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 1 112,396,214 - 112,461,164 (+) NCBI GRCh37 1 112,938,800 - 113,003,786 (+) RGD Build 36 1 112,740,383 - 112,803,739 (+) NCBI Archive Celera 1 111,169,369 - 111,234,318 (+) RGD HuRef 1 110,795,912 - 110,861,154 (+) RGD CHM1_1 1 113,053,632 - 113,118,610 (+) NCBI T2T-CHM13v2.0 1 112,408,508 - 112,473,705 (+) NCBI
Sequence:
AGCCGCTGTGGATGGGGAGTGGAGGCGGAGGGGAGCGGAGCCCGGAGCGTCGTGGAAAGCATTGGACACATTTCCACCATGCTAATGGCATTTTAAATATATTTGGCAATTTTCCCAATTTTTTACTG AAGAAAACTGTAAGTTTATACTTGAGGACTGAAGTGTGACTCTGCCGATTATCAGGCTTTCAAGATGAATCTGGAAAAACTCAGCAAGCCTGAACTCCTGACACTATTTAGTATTCTTGAAGGAGAGC TTGAAGCAAGGGACCTTGTTATAGAAGCCTTAAAGGCCCAACACAGAGATACTTTCATTGAAGAACGCTATGGAAAATATAACATCAGTGATCCTTTAATGGCTCTACAGAGAGATTTTGAAACACTG AAGGAGAAAAATGATGGCGAAAAGCAGCCAGTCTGCACAAATCCACTCTCTATTCTTAAGGTTGTGATGAAGCAGTGCAAGAACATGCAGGAGCGCATGCTGTCCCAGCTGGCTGCTGCTGAGAGCAG GCACCGAAAGGTGATCCTAGACCTTGAGGAAGAAAGGCAGCGGCATGCACAGGATACGGCTGAAGGAGATGATGTCACCTACATGCTAGAGAAGGAAAGAGAGAGGCTGACTCAACAGTTGGAATTTG AAAAATCCCAAGTGAAAAAGTTTGAAAAAGAACAGAAGAAGCTCTCTAGTCAGCTGGAAGAGGAGCGCTCCCGCCACAAGCAGCTCTCATCCATGCTAGTGCTTGAGTGCAAGAAAGCCACCAACAAG GCAGCCGAGGAAGGACAGAAGGCAGGAGAGCTGAGCCTGAAATTGGAGAAGGAGAAGAGCCGGGTGAGTAAACTGGAAGAAGAGTTGGCAGCTGAGAGAAAGAGAGGCTTGCAGACTGAGGCCCAGGT AGAGAAGCAGTTATCAGAGTTTGACATCGAAAGGGAACAACTGAGAGCAAAACTGAACCGAGAAGAGAACCGGACCAAAACCCTGAAAGAAGAAATGGAAAGTTTAAAGAAGATAGTGAAGGACCTAG AGGCTTCCCACCAGCACAGTAGCCCTAATGAGCAATTGAAGAAACCAGTAACCGTGTCCAAAGGCACAGCAACTGAGCCTCTCATGCTAATGTCTGTGTTTTGCCAAACAGAGAGTTTTCCAGCAGAA AGAACCCATGGGAGCAACATAGCCAAGATGACAAACACTGGGCTGCCTGGTCCTGCCACTCCTGCTTACTCATATGCAAAAACCAATGGCCATTGTGACCCAGAGATACAAACTACCAGGGAGCTGAC TGCAGGCAACAATGTAGAAAACCAGGTGCCTCCACGGGAAAAATCTGTGGCATTGGCCCAAGAGAAACCAGTGGAGAATGGTGGGTGTCCTGTGGGGATTGAGACTCCAGTCCCAATGCCCAGTCCCC TCTCTTCCAGTGGGAGCTCACTGTCTCCCAGCAGCACTGCCTCCTCCTCTCTAACATCCTCTCCTTGCTCTTCGCCGGTACTCACTAAGCGTTTATTGGGGTCATCAGCTAGCAGCCCTGGCTACCAG TCATCGTACCAAGTAGGGATCAACCAACGGTTCCATGCAGCTCGCCACAAATTTCAGTCCCAAGCAGATCAGGACCAACAAGCCAGTGGCCTACAGAGCCCTCCATCCAGGGATTTATCCCCCACCCT CATAGACAACTCTGCCGCCAAGCAGCTGGCCCGAAACACAGTCACTCAGGTGCTCTCCAGATTCACTAGCCAACAAGGGCCAATCAAGCCAGTCTCTCCCAACAGCTCTCCCTTTGGCACAGACTATC GAAATCTAGCCAACACTGCCAATCCAAGAGGTGACACAAGCCATTCACCTACTCCAGGGAAAGTGTCCAGTCCCCTGAGCCCCCTGTCTCCAGGAATCAAGTCCCCAACCATCCCCAGAGCTGAGAGA GGAAACCCTCCACCCATCCCACCCAAGAAACCTGGCCTCACCCCTTCTCCATCTGCTACCACTCCATTGACCAAAACTCATTCCCAGGCAGCCTCTTTGACCACTGCAGAAGACCTTGCCAGCAGCTG CTCTTCCAATACTGTTGTAGCAAATGGTAAGGATGTTGAGTTACTTTTGCCTACCAGCAGCTAGTCCCTAGGAGGGAGTCTCCACGTTTGACATTCCATCAGATTTCGTCCAAAAGCTCAGTCAGACT TCTGAGTCAGATTATGTTATTTATTTTGATAGTAGCTGAAACCATCTGTATAATACATTTAGTATATTTCACCATTTTGTATTTTTTTAAGTAGAAACTGAGTAGTTTGGATTTTTATGGCTCACATC TTTTTACTGAAGCCAGAAAGGCACCTCAAAGATGTCTCAAGCTCAGCAGTCACCGTCATGTTGTGATGAAGAAAGCGAATCACCAGGTGGTGATTTGCTATCTATTTGAGAACTAGAATCACTCAACA CTCATTTTGAATTATGCAGAAGTGGTTCATGCAGATTTTTATTCCAGATGAACATGTTTTAAAAGTGCCTGAAATATGACTGCCATATGAATGTGATTCTGCAGCAAAAAACACAAAATAGATCATTT AATTACAGAAAATGAGATCCTCTGTGAATTCTGAATGTTAAAAACCAACACTGCTTTTAATCCTCTTTTAATGTTTTAATACAAGCTTTGTGTTCTGAAACAAGGCTGCATAAGTAGAATGGGAATCC TTCTAAAGGTGGGTGTGAACTCACCACAAGCTGAGCTTTATAGAGCCCTTGAGAAACCCTCCTGAGCACTAAGCAGTTGGGGTGCTGATTTTCTTGTACTTTTGAAAAATTAAGTCACTCCCAGTTTC CTGCATAAGTTCTTGAACAGAATGAAATCACATCTCCATTCAAAAAATGTCTCAAGCATCTACTGTTGTGTAAGGAACTTCTGATTCTGATTGCTGTTACTTGAATAGGAAATGGTTACTCATTCTGT ATAAAAGTTTTGCAAGAGAATGAATTTTTTATTCTGTAATCAAAAAGCAATAACTTGAAATTCACTCTGTAATATTATAGGTCAGTCAGAATTATACAAGTTTTACCAAATTGTTACACTTATTCTCC AAGCTGCCAGAACCTGGTATCTGTATCTGTAAAACCAAATTAACTTTTGCTTAAATGGGAAGTATACATATATCTGTATAGATACATTACCCCTTTACATGTTTAACATACACACACTTAAACACATA AATACTAGTGTGATTATATCTTTGGAGTTTGCAATATAGCATAAAGGACAAGTAGAACTGCACATTAAGATTACCTACCGAAGCAACTAGATGTGGCTGGGACACAATCAAAGGAGGAATTTTGTCCA CAGGAAGGTGAGGAAATTCCAAATGAAGCCTAGATCTTCAGTATCATAAAAAGGCAGAGCTGGCCAGGCACAGTGGCTCATGCCTGTAATCTTATCACTTTGGGAGGCTGAGATGGGAGGATCTCTTG AGACCAGGTGTTCAAGACCAGCCTCATCAACATAGTGAGACCCCATCTCTATTAAAAAAATAAATAGGCAGAGCTAAACTAACCCCAGTGTCACAAAACTCAACTGGTCATATAAATGAGTGAAACAG GCCTCTCACACAAGCGATGTAAAACAGCTGGGAGCAGTGGGAGCTGTGGCAAACTAAAGTGCCCAAGCCGCATTTAAAAAGGGCATCTGTTCAGCTCCATCTGCTTGCTGCGGTGCAAGAATGCTAAA CCAGGATTACCAGTTCTTCACATTTTTTGAAATCCAAATTTTCATGAGAAACATTCTCATTTTTAAATATCAAGAAGTGATTTTAAAATGTTTAAATGGTGCTGGTTAAACAAACACGTCTGCAGCTG GATTTAGCTTGCAAGCTGCCAAGTTGCAACCTCTTTCATTCTAGAAACTTCTGTCATTTTCATCATAGCAAGTCTATGCGGACAAAAGCCTCCAAACTTTCCAACTGTGTAGGCCAGTACAGCTGGCA AGGTTCATAGAATATAATGGCTATCCCCCTCTGCCAAATAAGACTATCCACAACCCAGCTCAGACACAGTGGTTATATGATTTTGTGTCCATACAGGAGAGGCCTTGGTGTCTTCACATACATTCTCT GAGCCAACATCTATCCAGCAGCCCTGACCTCCTGCTATAATTTAAGTCTATTTCCTTTTAATCTAATAAGAGTTGATAGTAAAAAGGCAGGTGATGGAAATCAGTGTATAAATCACAATGGAGTATAT TGGCAACTCCACAGCTTATAGTTTGATAAAGGCAAATACATGAAAAATAAAAATGCTACTAATGCCCCAAGGTGTCTATCAAAATGATGTAGGGGGTATCTTAAACTGTCCAAGGCAATCATGCATTG AACTTTATTCCTATGCAGAGCCAAAACGAATAGTGTTGATAAAATAGCTAAACTTTCTAAACTGGAGAGGAGGCTACAGTGCCAGAGAGTTATTGTCTCTTTTGCTTTAAATGGTAATCTTAAAAGTT GCATTGTGCTCTTCCTTTGTTTTGGGATAGATATATATAGAGAGAGATACTATAAGGAAGTTTATTTCTTAGGAAGTGCACTGAATAATGTATTTCTTTTACAGTGTAATATGGGGGTGGGGATATGC GAAAGAAATGTGTATTTTTGCTAGTTGCCTACCTTCTGAGATAAATAAGCACAATCTTGCAATGGATCCAATAACCCAGTTAGGTATTATAGATTAGTATTTAAGTTTGCTGTAGATTGTGTGTGTGT GTGCTAAGTAAAAGTTCCATGATTCACAATTTTAGTATTAACCCATGTTGCAAAAGCTGTTACTGGCCAACAGATTGTAATGATGTGTACCATATAACACAAGCATTAACTAGGCATTAACGTTTGTA AAGCCAAATATACCATGCAGAAGTCTTCATTTTTATAGCAGACTGCATTAAAACAAGTTAAATCTTGCTGTTTGGGGGGAAATAGTCTTGTTTGTACAAAGTGAAAAATGGCACAATTTGGGCATATT TTGTTGGGAAGAGGGGGTGGTGTAGAGGGAGCACTTGACTGTGGCTTTGACAAAACAAATGAAGTCAATGACCCATCCAGGTTAGACTCCATAAGGAACTAAGACATTGATTTTCTTTAGAGTCTTAG AGCTGGAAAAAGCCTTTACAATAATCCAGTCTGTGATTTTTTAAACCTTTTGGTGGTTCTGGACCTTTTTGAGAATCTTAGAAAAGCCATGGAGTTTATCCCTAGAAAAATGAATATGCCTATATGCA AAATTTGTTTGATGGCTTCATAGGATCCAAAGACCCTGAAGCCATCCATGGCTCATGTATTTCTGCTTAAGAAAGCATAATCTTGTTCTGCTCTCTCATTTTACAAATGATTAATGCATCCCTTTTCA ACTACTCCAGCGCTGTTGCTGCTGCAATGTTAGCAAATGCAAGCCAGAGAGAAGCACTTGAAAATCCTTTGATGTCTAAAAAATGTTCAAATAGTGTGGATGTTTACATATCTGAAGTTTTCAGCATT TAAGCAAATTAATGATCATTTCAACAAATACTAGCATATCCGGTTTCCCTTAATAGCCTGTCAGCAGTGCTGCCTTGTCAATTTGTGTGTGTGTGTGTGTATGTGTGTGTGTGTGTGAATTCATAAGG AGTGCTTCTGATGCTTAGTCCTTGAAATGGAACTTCAACTGTCTTTCAAAACACTGGCTTCAAAATAGGATGTGTTTTCCTAATGAATCAGAAGTGGGCAATGAGCATTGTTCCACAGGAATAATTTT TAATTTAATTTCTATAAAACTAGTTGAGAAATGAGAGCCTGTCCACCCACCATTTGTGTATCAGTGGCCAATTCATTAGTAAAAATAAAGGAGGGGAAAGGAGA
hide sequence
RefSeq Acc Id:
XM_011541781 ⟹ XP_011540083
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 1 112,396,214 - 112,461,164 (+) NCBI
Sequence:
CTCCCGGTATTCCCCGAGGAGGCGGCTCCTCATCCTCCGAGGGTCCTCACAGCTACTTTTTGTCCCTCGTCGATTCCCAGCTCCTCAGAAGGGGCTTCCCTCTGACACCCCTCATTCAAAGGCACCTC CCACCCCGCACCTCAGCCTTGGCGGAGAGGACTCACAGCATTGGACACATTTCCACCATGCTAATGGCATTTTAAATATATTTGGCAATTTTCCCAATTTTTTACTGAAGAAAACTGTAAGTTTATAC TTGAGGACTGAAGTGTGACTCTGCCGATTATCAGGCTTTCAAGATGAATCTGGAAAAACTCAGCAAGCCTGAACTCCTGACACTATTTAGTATTCTTGAAGGAGAGCTTGAAGCAAGGGACCTTGTTA TAGAAGCCTTAAAGGCCCAACACAGAGATACTTTCATTGAAGAACGCTATGGAAAATATAACATCAGTGATCCTTTAATGGCTCTACAGAGAGATTTTGAAACACTGAAGGAGAAAAATGATGGCGAA AAGCAGCCAGTCTGCACAAATCCACTCTCTATTCTTAAGGTTGTGATGAAGCAGTGCAAGAACATGCAGGAGCGCATGCTGTCCCAGCTGGCTGCTGCTGAGAGCAGGCACCGAAAGGTGATCCTAGA CCTTGAGGAAGAAAGGCAGCGGCATGCACAGGATACGGCTGAAGGAGATGATGTCACCTACATGCTAGAGAAGGAAAGAGAGAGGCTGACTCAACAGTTGGAATTTGAAAAATCCCAAGTGAAAAAGT TTGAAAAAGAACAGAAGAAGCTCTCTAGTCAGCTGGAAGAGGAGCGCTCCCGCCACAAGCAGCTCTCATCCATGCTAGTGCTTGAGTGCAAGAAAGCCACCAACAAGGCAGCCGAGGAAGGACAGAAG GCAGGAGAGCTGAGCCTGAAATTGGAGAAGGAGAAGAGCCGGGTGAGTAAACTGGAAGAAGAGTTGGCAGCTGAGAGAAAGAGAGGCTTGCAGACTGAGGCCCAGGTAGAGAAGCAGTTATCAGAGTT TGACATCGAAAGGGAACAACTGAGAGCAAAACTGAACCGAGAAGAGAACCGGACCAAAACCCTGAAAGAAGAAATGGAAAGTTTAAAGAAGATAGTGAAGGACCTAGAGGCTTCCCACCAGCACAGTA GCCCTAATGAGCAATTGAAGAAACCAGTAACCGTGTCCAAAGGCACAGCAACTGAGCCTCTCATGCTAATGTCTGTGTTTTGCCAAACAGAGAGTTTTCCAGCAGAAAGAACCCATGGGAGCAACATA GCCAAGATGACAAACACTGGGCTGCCTGGTCCTGCCACTCCTGCTTACTCATATGCAAAAACCAATGGCCATTGTGACCCAGAGATACAAACTACCAGGGAGCTGACTGCAGGCAACAATGTAGAAAA CCAGGTGCCTCCACGGGAAAAATCTGTGGCATTGGCCCAAGAGAAACCAGTGGAGAATGGTGGGTGTCCTGTGGGGATTGAGACTCCAGTCCCAATGCCCAGTCCCCTCTCTTCCAGTGGGAGCTCAC TGTCTCCCAGCAGCACTGCCTCCTCCTCTCTAACATCCTCTCCTTGCTCTTCGCCGGTACTCACTAAGCGTTTATTGGGGTCATCAGCTAGCAGCCCTGGCTACCAGTCATCGTACCAAGTAGGGATC AACCAACGGTTCCATGCAGCTCGCCACAAATTTCAGTCCCAAGCAGATCAGGACCAACAAGCCAGTGGCCTACAGAGCCCTCCATCCAGGGATTTATCCCCCACCCTCATAGACAACTCTGCCGCCAA GCAGCTGGCCCGAAACACAGTCACTCAGGTGCTCTCCAGATTCACTAGCCAACAAGGGCCAATCAAGCCAGTCTCTCCCAACAGCTCTCCCTTTGGCACAGACTATCGAAATCTAGCCAACACTGCCA ATCCAAGAGGTGACACAAGCCATTCACCTACTCCAGGGAAAGTGTCCAGTCCCCTGAGCCCCCTGTCTCCAGGAATCAAGTCCCCAACCATCCCCAGAGCTGAGAGAGGAAACCCTCCACCCATCCCA CCCAAGAAACCTGGCCTCACCCCTTCTCCATCTGCTACCACTCCATTGACCAAAACTCATTCCCAGGCAGCCTCTTTGACCACTGCAGAAGACCTTGCCAGCAGCTGCTCTTCCAATACTGTTGTAGC AAATGGTAAGGATGTTGAGTTACTTTTGCCTACCAGCAGCTAGTCCCTAGGAGGGAGTCTCCACGTTTGACATTCCATCAGATTTCGTCCAAAAGCTCAGTCAGACTTCTGAGTCAGATTATGTTATT TATTTTGATAGTAGCTGAAACCATCTGTATAATACATTTAGTATATTTCACCATTTTGTATTTTTTTAAGTAGAAACTGAGTAGTTTGGATTTTTATGGCTCACATCTTTTTACTGAAGCCAGAAAGG CACCTCAAAGATGTCTCAAGCTCAGCAGTCACCGTCATGTTGTGATGAAGAAAGCGAATCACCAGGTGGTGATTTGCTATCTATTTGAGAACTAGAATCACTCAACACTCATTTTGAATTATGCAGAA GTGGTTCATGCAGATTTTTATTCCAGATGAACATGTTTTAAAAGTGCCTGAAATATGACTGCCATATGAATGTGATTCTGCAGCAAAAAACACAAAATAGATCATTTAATTACAGAAAATGAGATCCT CTGTGAATTCTGAATGTTAAAAACCAACACTGCTTTTAATCCTCTTTTAATGTTTTAATACAAGCTTTGTGTTCTGAAACAAGGCTGCATAAGTAGAATGGGAATCCTTCTAAAGGTGGGTGTGAACT CACCACAAGCTGAGCTTTATAGAGCCCTTGAGAAACCCTCCTGAGCACTAAGCAGTTGGGGTGCTGATTTTCTTGTACTTTTGAAAAATTAAGTCACTCCCAGTTTCCTGCATAAGTTCTTGAACAGA ATGAAATCACATCTCCATTCAAAAAATGTCTCAAGCATCTACTGTTGTGTAAGGAACTTCTGATTCTGATTGCTGTTACTTGAATAGGAAATGGTTACTCATTCTGTATAAAAGTTTTGCAAGAGAAT GAATTTTTTATTCTGTAATCAAAAAGCAATAACTTGAAATTCACTCTGTAATATTATAGGTCAGTCAGAATTATACAAGTTTTACCAAATTGTTACACTTATTCTCCAAGCTGCCAGAACCTGGTATC TGTATCTGTAAAACCAAATTAACTTTTGCTTAAATGGGAAGTATACATATATCTGTATAGATACATTACCCCTTTACATGTTTAACATACACACACTTAAACACATAAATACTAGTGTGATTATATCT TTGGAGTTTGCAATATAGCATAAAGGACAAGTAGAACTGCACATTAAGATTACCTACCGAAGCAACTAGATGTGGCTGGGACACAATCAAAGGAGGAATTTTGTCCACAGGAAGGTGAGGAAATTCCA AATGAAGCCTAGATCTTCAGTATCATAAAAAGGCAGAGCTGGCCAGGCACAGTGGCTCATGCCTGTAATCTTATCACTTTGGGAGGCTGAGATGGGAGGATCTCTTGAGACCAGGTGTTCAAGACCAG CCTCATCAACATAGTGAGACCCCATCTCTATTAAAAAAATAAATAGGCAGAGCTAAACTAACCCCAGTGTCACAAAACTCAACTGGTCATATAAATGAGTGAAACAGGCCTCTCACACAAGCGATGTA AAACAGCTGGGAGCAGTGGGAGCTGTGGCAAACTAAAGTGCCCAAGCCGCATTTAAAAAGGGCATCTGTTCAGCTCCATCTGCTTGCTGCGGTGCAAGAATGCTAAACCAGGATTACCAGTTCTTCAC ATTTTTTGAAATCCAAATTTTCATGAGAAACATTCTCATTTTTAAATATCAAGAAGTGATTTTAAAATGTTTAAATGGTGCTGGTTAAACAAACACGTCTGCAGCTGGATTTAGCTTGCAAGCTGCCA AGTTGCAACCTCTTTCATTCTAGAAACTTCTGTCATTTTCATCATAGCAAGTCTATGCGGACAAAAGCCTCCAAACTTTCCAACTGTGTAGGCCAGTACAGCTGGCAAGGTTCATAGAATATAATGGC TATCCCCCTCTGCCAAATAAGACTATCCACAACCCAGCTCAGACACAGTGGTTATATGATTTTGTGTCCATACAGGAGAGGCCTTGGTGTCTTCACATACATTCTCTGAGCCAACATCTATCCAGCAG CCCTGACCTCCTGCTATAATTTAAGTCTATTTCCTTTTAATCTAATAAGAGTTGATAGTAAAAAGGCAGGTGATGGAAATCAGTGTATAAATCACAATGGAGTATATTGGCAACTCCACAGCTTATAG TTTGATAAAGGCAAATACATGAAAAATAAAAATGCTACTAATGCCCCAAGGTGTCTATCAAAATGATGTAGGGGGTATCTTAAACTGTCCAAGGCAATCATGCATTGAACTTTATTCCTATGCAGAGC CAAAACGAATAGTGTTGATAAAATAGCTAAACTTTCTAAACTGGAGAGGAGGCTACAGTGCCAGAGAGTTATTGTCTCTTTTGCTTTAAATGGTAATCTTAAAAGTTGCATTGTGCTCTTCCTTTGTT TTGGGATAGATATATATAGAGAGAGATACTATAAGGAAGTTTATTTCTTAGGAAGTGCACTGAATAATGTATTTCTTTTACAGTGTAATATGGGGGTGGGGATATGCGAAAGAAATGTGTATTTTTGC TAGTTGCCTACCTTCTGAGATAAATAAGCACAATCTTGCAATGGATCCAATAACCCAGTTAGGTATTATAGATTAGTATTTAAGTTTGCTGTAGATTGTGTGTGTGTGTGCTAAGTAAAAGTTCCATG ATTCACAATTTTAGTATTAACCCATGTTGCAAAAGCTGTTACTGGCCAACAGATTGTAATGATGTGTACCATATAACACAAGCATTAACTAGGCATTAACGTTTGTAAAGCCAAATATACCATGCAGA AGTCTTCATTTTTATAGCAGACTGCATTAAAACAAGTTAAATCTTGCTGTTTGGGGGGAAATAGTCTTGTTTGTACAAAGTGAAAAATGGCACAATTTGGGCATATTTTGTTGGGAAGAGGGGGTGGT GTAGAGGGAGCACTTGACTGTGGCTTTGACAAAACAAATGAAGTCAATGACCCATCCAGGTTAGACTCCATAAGGAACTAAGACATTGATTTTCTTTAGAGTCTTAGAGCTGGAAAAAGCCTTTACAA TAATCCAGTCTGTGATTTTTTAAACCTTTTGGTGGTTCTGGACCTTTTTGAGAATCTTAGAAAAGCCATGGAGTTTATCCCTAGAAAAA
hide sequence
RefSeq Acc Id:
XM_017001806 ⟹ XP_016857295
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 1 112,391,087 - 112,461,164 (+) NCBI
Sequence:
GCAGATCCAAGCAAGAAGAGAACGTTTAAGGACTGCCCAGCAAATCCTTTGTGGGAACAAATGATGGGAGAAAATGCAGAAATGCAGGGGGCAGTGGAGGGCACACCTTGCCTTCGGCTTCAGCCTGG TCCGGGGCTTGGAGAGCCCTCTCTGGCTTTCAGACTTTGACCTCCTCATCAACCCCGGGGAGAAGGGGTGGGGTCGGGAAGCGTGAGGAAAAGGAGATAGTGAAGACAAGCCAGAAGAAAGAAAGCAT TTCTTTTCATCACTTTTCCCATTCATTTCAACTTCTACATCTAGCTCACTCAGCACTCAGCATCTTAATAAGTCCCAGTCCAGTGGGCCACAGCTAGAAGGAGCCTTATGGAGTCCCAGATGTTTAGT TGGAGCCTAGGACTCAGAGAAGAGGATTGAGCAAGATCTCCCAGGTAGCTAATACTTCCATGTACATCAGATCGCTTGGATACTGACAACCACCTGGTCTTGTAGACAGGAGCTATTATCTCATTTAA CAAATGAGGAAACAAGTTCAGCATTGGACACATTTCCACCATGCTAATGGCATTTTAAATATATTTGGCAATTTTCCCAATTTTTTACTGAAGAAAACTGTAAGTTTATACTTGAGGACTGAAGTGTG ACTCTGCCGATTATCAGGCTTTCAAGATGAATCTGGAAAAACTCAGCAAGCCTGAACTCCTGACACTATTTAGTATTCTTGAAGGAGAGCTTGAAGCAAGGGACCTTGTTATAGAAGCCTTAAAGGCC CAACACAGAGATACTTTCATTGAAGAACGCTATGGAAAATATAACATCAGTGATCCTTTAATGGCTCTACAGAGAGATTTTGAAACACTGAAGGAGAAAAATGATGGCGAAAAGCAGCCAGTCTGCAC AAATCCACTCTCTATTCTTAAGGTTGTGATGAAGCAGTGCAAGAACATGCAGGAGCGCATGCTGTCCCAGCTGGCTGCTGCTGAGAGCAGGCACCGAAAGGTGATCCTAGACCTTGAGGAAGAAAGGC AGCGGCATGCACAGGATACGGCTGAAGGAGATGATGTCACCTACATGCTAGAGAAGGAAAGAGAGAGGCTGACTCAACAGTTGGAATTTGAAAAATCCCAAGTGAAAAAGTTTGAAAAAGAACAGAAG AAGCTCTCTAGTCAGCTGGAAGAGGAGCGCTCCCGCCACAAGCAGCTCTCATCCATGCTAGTGCTTGAGTGCAAGAAAGCCACCAACAAGGCAGCCGAGGAAGGACAGAAGGCAGGAGAGCTGAGCCT GAAATTGGAGAAGGAGAAGAGCCGGGTGAGTAAACTGGAAGAAGAGTTGGCAGCTGAGAGAAAGAGAGGCTTGCAGACTGAGGCCCAGGTAGAGAAGCAGTTATCAGAGTTTGACATCGAAAGGGAAC AACTGAGAGCAAAACTGAACCGAGAAGAGAACCGGACCAAAACCCTGAAAGAAGAAATGGAAAGTTTAAAGAAGATAGTGAAGGACCTAGAGGCTTCCCACCAGCACAGTAGCCCTAATGAGCAATTG AAGAAACCAGTAACCGTGTCCAAAGGCACAGCAACTGAGCCTCTCATGCTAATGTCTGTGTTTTGCCAAACAGAGAGTTTTCCAGCAGAAAGAACCCATGGGAGCAACATAGCCAAGATGACAAACAC TGGGCTGCCTGGTCCTGCCACTCCTGCTTACTCATATGCAAAAACCAATGGCCATTGTGACCCAGAGATACAAACTACCAGGGAGCTGACTGCAGGCAACAATGTAGAAAACCAGGTGCCTCCACGGG AAAAATCTGTGGCATTGGCCCAAGAGAAACCAGTGGAGAATGGTGGGTGTCCTGTGGGGATTGAGACTCCAGTCCCAATGCCCAGTCCCCTCTCTTCCAGTGGGAGCTCACTGTCTCCCAGCAGCACT GCCTCCTCCTCTCTAACATCCTCTCCTTGCTCTTCGCCGGTACTCACTAAGCGTTTATTGGGGTCATCAGCTAGCAGCCCTGGCTACCAGTCATCGTACCAAGTAGGGATCAACCAACGGTTCCATGC AGCTCGCCACAAATTTCAGTCCCAAGCAGATCAGGACCAACAAGCCAGTGGCCTACAGAGCCCTCCATCCAGGGATTTATCCCCCACCCTCATAGACAACTCTGCCGCCAAGCAGCTGGCCCGAAACA CAGTCACTCAGGTGCTCTCCAGATTCACTAGCCAACAAGGGCCAATCAAGCCAGTCTCTCCCAACAGCTCTCCCTTTGGCACAGACTATCGAAATCTAGCCAACACTGCCAATCCAAGAGGTGACACA AGCCATTCACCTACTCCAGGGAAAGTGTCCAGTCCCCTGAGCCCCCTGTCTCCAGGAATCAAGTCCCCAACCATCCCCAGAGCTGAGAGAGGAAACCCTCCACCCATCCCACCCAAGAAACCTGGCCT CACCCCTTCTCCATCTGCTACCACTCCATTGACCAAAACTCATTCCCAGGCAGCCTCTTTGACCACTGCAGAAGACCTTGCCAGCAGCTGCTCTTCCAATACTGTTGTAGCAAATGGTAAGGATGTTG AGTTACTTTTGCCTACCAGCAGCTAGTCCCTAGGAGGGAGTCTCCACGTTTGACATTCCATCAGATTTCGTCCAAAAGCTCAGTCAGACTTCTGAGTCAGATTATGTTATTTATTTTGATAGTAGCTG AAACCATCTGTATAATACATTTAGTATATTTCACCATTTTGTATTTTTTTAAGTAGAAACTGAGTAGTTTGGATTTTTATGGCTCACATCTTTTTACTGAAGCCAGAAAGGCACCTCAAAGATGTCTC AAGCTCAGCAGTCACCGTCATGTTGTGATGAAGAAAGCGAATCACCAGGTGGTGATTTGCTATCTATTTGAGAACTAGAATCACTCAACACTCATTTTGAATTATGCAGAAGTGGTTCATGCAGATTT TTATTCCAGATGAACATGTTTTAAAAGTGCCTGAAATATGACTGCCATATGAATGTGATTCTGCAGCAAAAAACACAAAATAGATCATTTAATTACAGAAAATGAGATCCTCTGTGAATTCTGAATGT TAAAAACCAACACTGCTTTTAATCCTCTTTTAATGTTTTAATACAAGCTTTGTGTTCTGAAACAAGGCTGCATAAGTAGAATGGGAATCCTTCTAAAGGTGGGTGTGAACTCACCACAAGCTGAGCTT TATAGAGCCCTTGAGAAACCCTCCTGAGCACTAAGCAGTTGGGGTGCTGATTTTCTTGTACTTTTGAAAAATTAAGTCACTCCCAGTTTCCTGCATAAGTTCTTGAACAGAATGAAATCACATCTCCA TTCAAAAAATGTCTCAAGCATCTACTGTTGTGTAAGGAACTTCTGATTCTGATTGCTGTTACTTGAATAGGAAATGGTTACTCATTCTGTATAAAAGTTTTGCAAGAGAATGAATTTTTTATTCTGTA ATCAAAAAGCAATAACTTGAAATTCACTCTGTAATATTATAGGTCAGTCAGAATTATACAAGTTTTACCAAATTGTTACACTTATTCTCCAAGCTGCCAGAACCTGGTATCTGTATCTGTAAAACCAA ATTAACTTTTGCTTAAATGGGAAGTATACATATATCTGTATAGATACATTACCCCTTTACATGTTTAACATACACACACTTAAACACATAAATACTAGTGTGATTATATCTTTGGAGTTTGCAATATA GCATAAAGGACAAGTAGAACTGCACATTAAGATTACCTACCGAAGCAACTAGATGTGGCTGGGACACAATCAAAGGAGGAATTTTGTCCACAGGAAGGTGAGGAAATTCCAAATGAAGCCTAGATCTT CAGTATCATAAAAAGGCAGAGCTGGCCAGGCACAGTGGCTCATGCCTGTAATCTTATCACTTTGGGAGGCTGAGATGGGAGGATCTCTTGAGACCAGGTGTTCAAGACCAGCCTCATCAACATAGTGA GACCCCATCTCTATTAAAAAAATAAATAGGCAGAGCTAAACTAACCCCAGTGTCACAAAACTCAACTGGTCATATAAATGAGTGAAACAGGCCTCTCACACAAGCGATGTAAAACAGCTGGGAGCAGT GGGAGCTGTGGCAAACTAAAGTGCCCAAGCCGCATTTAAAAAGGGCATCTGTTCAGCTCCATCTGCTTGCTGCGGTGCAAGAATGCTAAACCAGGATTACCAGTTCTTCACATTTTTTGAAATCCAAA TTTTCATGAGAAACATTCTCATTTTTAAATATCAAGAAGTGATTTTAAAATGTTTAAATGGTGCTGGTTAAACAAACACGTCTGCAGCTGGATTTAGCTTGCAAGCTGCCAAGTTGCAACCTCTTTCA TTCTAGAAACTTCTGTCATTTTCATCATAGCAAGTCTATGCGGACAAAAGCCTCCAAACTTTCCAACTGTGTAGGCCAGTACAGCTGGCAAGGTTCATAGAATATAATGGCTATCCCCCTCTGCCAAA TAAGACTATCCACAACCCAGCTCAGACACAGTGGTTATATGATTTTGTGTCCATACAGGAGAGGCCTTGGTGTCTTCACATACATTCTCTGAGCCAACATCTATCCAGCAGCCCTGACCTCCTGCTAT AATTTAAGTCTATTTCCTTTTAATCTAATAAGAGTTGATAGTAAAAAGGCAGGTGATGGAAATCAGTGTATAAATCACAATGGAGTATATTGGCAACTCCACAGCTTATAGTTTGATAAAGGCAAATA CATGAAAAATAAAAATGCTACTAATGCCCCAAGGTGTCTATCAAAATGATGTAGGGGGTATCTTAAACTGTCCAAGGCAATCATGCATTGAACTTTATTCCTATGCAGAGCCAAAACGAATAGTGTTG ATAAAATAGCTAAACTTTCTAAACTGGAGAGGAGGCTACAGTGCCAGAGAGTTATTGTCTCTTTTGCTTTAAATGGTAATCTTAAAAGTTGCATTGTGCTCTTCCTTTGTTTTGGGATAGATATATAT AGAGAGAGATACTATAAGGAAGTTTATTTCTTAGGAAGTGCACTGAATAATGTATTTCTTTTACAGTGTAATATGGGGGTGGGGATATGCGAAAGAAATGTGTATTTTTGCTAGTTGCCTACCTTCTG AGATAAATAAGCACAATCTTGCAATGGATCCAATAACCCAGTTAGGTATTATAGATTAGTATTTAAGTTTGCTGTAGATTGTGTGTGTGTGTGCTAAGTAAAAGTTCCATGATTCACAATTTTAGTAT TAACCCATGTTGCAAAAGCTGTTACTGGCCAACAGATTGTAATGATGTGTACCATATAACACAAGCATTAACTAGGCATTAACGTTTGTAAAGCCAAATATACCATGCAGAAGTCTTCATTTTTATAG CAGACTGCATTAAAACAAGTTAAATCTTGCTGTTTGGGGGGAAATAGTCTTGTTTGTACAAAGTGAAAAATGGCACAATTTGGGCATATTTTGTTGGGAAGAGGGGGTGGTGTAGAGGGAGCACTTGA CTGTGGCTTTGACAAAACAAATGAAGTCAATGACCCATCCAGGTTAGACTCCATAAGGAACTAAGACATTGATTTTCTTTAGAGTCTTAGAGCTGGAAAAAGCCTTTACAATAATCCAGTCTGTGATT TTTTAAACCTTTTGGTGGTTCTGGACCTTTTTGAGAATCTTAGAAAAGCCATGGAGTTTATCCCTAGAAAAA
hide sequence
RefSeq Acc Id:
XM_047425362 ⟹ XP_047281318
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source GRCh38 1 112,411,707 - 112,461,164 (+) NCBI
RefSeq Acc Id:
XM_054337703 ⟹ XP_054193678
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 1 112,408,561 - 112,473,705 (+) NCBI
RefSeq Acc Id:
XM_054337704 ⟹ XP_054193679
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 1 112,423,983 - 112,473,705 (+) NCBI
RefSeq Acc Id:
XM_054337705 ⟹ XP_054193680
Type:
CODING
Position:
Human Assembly Chr Position (strand) Source T2T-CHM13v2.0 1 112,403,339 - 112,473,705 (+) NCBI
RefSeq Acc Id:
NP_061174 ⟸ NM_018704
- UniProtKB:
B3KMS5 (UniProtKB/Swiss-Prot), Q96B40 (UniProtKB/Swiss-Prot), Q9P2B4 (UniProtKB/Swiss-Prot)
- Sequence:
MNLEKLSKPELLTLFSILEGELEARDLVIEALKAQHRDTFIEERYGKYNISDPLMALQRDFETLKEKNDGEKQPVCTNPLSILKVVMKQCKNMQERMLSQLAAAESRHRKVILDLEEERQRHAQDTAE GDDVTYMLEKERERLTQQLEFEKSQVKKFEKEQKKLSSQLEEERSRHKQLSSMLVLECKKATNKAAEEGQKAGELSLKLEKEKSRVSKLEEELAAERKRGLQTEAQVEKQLSEFDIEREQLRAKLNRE ENRTKTLKEEMESLKKIVKDLEASHQHSSPNEQLKKPVTVSKGTATEPLMLMSVFCQTESFPAERTHGSNIAKMTNTGLPGPATPAYSYAKTNGHCDPEIQTTRELTAGNNVENQVPPREKSVALAQE KPVENGGCPVGIETPVPMPSPLSSSGSSLSPSSTASSSLTSSPCSSPVLTKRLLGSSASSPGYQSSYQVGINQRFHAARHKFQSQADQDQQASGLQSPPSRDLSPTLIDNSAAKQLARNTVTQVLSRF TSQQGPIKPVSPNSSPFGTDYRNLANTANPRGDTSHSPTPGKVSSPLSPLSPGIKSPTIPRAERGNPPPIPPKKPGLTPSPSATTPLTKTHSQAASLTTAEDLASSCSSNTVVANGKDVELLLPTSS
hide sequence
RefSeq Acc Id:
XP_011540083 ⟸ XM_011541781
- Peptide Label:
isoform X1
- UniProtKB:
B3KMS5 (UniProtKB/Swiss-Prot), Q96B40 (UniProtKB/Swiss-Prot), Q9P2B4 (UniProtKB/Swiss-Prot)
- Sequence:
MNLEKLSKPELLTLFSILEGELEARDLVIEALKAQHRDTFIEERYGKYNISDPLMALQRDFETLKEKNDGEKQPVCTNPLSILKVVMKQCKNMQERMLSQLAAAESRHRKVILDLEEERQRHAQDTAE GDDVTYMLEKERERLTQQLEFEKSQVKKFEKEQKKLSSQLEEERSRHKQLSSMLVLECKKATNKAAEEGQKAGELSLKLEKEKSRVSKLEEELAAERKRGLQTEAQVEKQLSEFDIEREQLRAKLNRE ENRTKTLKEEMESLKKIVKDLEASHQHSSPNEQLKKPVTVSKGTATEPLMLMSVFCQTESFPAERTHGSNIAKMTNTGLPGPATPAYSYAKTNGHCDPEIQTTRELTAGNNVENQVPPREKSVALAQE KPVENGGCPVGIETPVPMPSPLSSSGSSLSPSSTASSSLTSSPCSSPVLTKRLLGSSASSPGYQSSYQVGINQRFHAARHKFQSQADQDQQASGLQSPPSRDLSPTLIDNSAAKQLARNTVTQVLSRF TSQQGPIKPVSPNSSPFGTDYRNLANTANPRGDTSHSPTPGKVSSPLSPLSPGIKSPTIPRAERGNPPPIPPKKPGLTPSPSATTPLTKTHSQAASLTTAEDLASSCSSNTVVANGKDVELLLPTSS
hide sequence
RefSeq Acc Id:
XP_016857295 ⟸ XM_017001806
- Peptide Label:
isoform X1
- UniProtKB:
B3KMS5 (UniProtKB/Swiss-Prot), Q96B40 (UniProtKB/Swiss-Prot), Q9P2B4 (UniProtKB/Swiss-Prot)
- Sequence:
MNLEKLSKPELLTLFSILEGELEARDLVIEALKAQHRDTFIEERYGKYNISDPLMALQRDFETLKEKNDGEKQPVCTNPLSILKVVMKQCKNMQERMLSQLAAAESRHRKVILDLEEERQRHAQDTAE GDDVTYMLEKERERLTQQLEFEKSQVKKFEKEQKKLSSQLEEERSRHKQLSSMLVLECKKATNKAAEEGQKAGELSLKLEKEKSRVSKLEEELAAERKRGLQTEAQVEKQLSEFDIEREQLRAKLNRE ENRTKTLKEEMESLKKIVKDLEASHQHSSPNEQLKKPVTVSKGTATEPLMLMSVFCQTESFPAERTHGSNIAKMTNTGLPGPATPAYSYAKTNGHCDPEIQTTRELTAGNNVENQVPPREKSVALAQE KPVENGGCPVGIETPVPMPSPLSSSGSSLSPSSTASSSLTSSPCSSPVLTKRLLGSSASSPGYQSSYQVGINQRFHAARHKFQSQADQDQQASGLQSPPSRDLSPTLIDNSAAKQLARNTVTQVLSRF TSQQGPIKPVSPNSSPFGTDYRNLANTANPRGDTSHSPTPGKVSSPLSPLSPGIKSPTIPRAERGNPPPIPPKKPGLTPSPSATTPLTKTHSQAASLTTAEDLASSCSSNTVVANGKDVELLLPTSS
hide sequence
Ensembl Acc Id:
ENSP00000390976 ⟸ ENST00000441739
Ensembl Acc Id:
ENSP00000271277 ⟸ ENST00000271277
RefSeq Acc Id:
XP_047281318 ⟸ XM_047425362
- Peptide Label:
isoform X1
- UniProtKB:
Q9P2B4 (UniProtKB/Swiss-Prot), B3KMS5 (UniProtKB/Swiss-Prot), Q96B40 (UniProtKB/Swiss-Prot)
RefSeq Acc Id:
XP_054193680 ⟸ XM_054337705
- Peptide Label:
isoform X1
- UniProtKB:
Q96B40 (UniProtKB/Swiss-Prot), Q9P2B4 (UniProtKB/Swiss-Prot), B3KMS5 (UniProtKB/Swiss-Prot)
RefSeq Acc Id:
XP_054193678 ⟸ XM_054337703
- Peptide Label:
isoform X1
- UniProtKB:
Q96B40 (UniProtKB/Swiss-Prot), Q9P2B4 (UniProtKB/Swiss-Prot), B3KMS5 (UniProtKB/Swiss-Prot)
RefSeq Acc Id:
XP_054193679 ⟸ XM_054337704
- Peptide Label:
isoform X1
- UniProtKB:
Q96B40 (UniProtKB/Swiss-Prot), Q9P2B4 (UniProtKB/Swiss-Prot), B3KMS5 (UniProtKB/Swiss-Prot)
RGD ID: 6856638
Promoter ID: EPDNEW_H1484
Type: initiation region
Name: CTTNBP2NL_1
Description: CTTNBP2 N-terminal like
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H1485
Experiment Methods: Single-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 1 112,396,214 - 112,396,274 EPDNEW
RGD ID: 6856640
Promoter ID: EPDNEW_H1485
Type: initiation region
Name: CTTNBP2NL_2
Description: CTTNBP2 N-terminal like
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Alternative Promoters: null; see alsoEPDNEW_H1484
Experiment Methods: Single-end sequencing.
Position: Human Assembly Chr Position (strand) Source GRCh38 1 112,396,458 - 112,396,518 EPDNEW
RGD ID: 6785008
Promoter ID: HG_KWN:4149
Type: CpG-Island
SO ACC ID: SO:0000170
Source: MPROMDB
Tissues & Cell Lines: CD4+TCell, CD4+TCell_12Hour, HeLa_S3, K562, Lymphoblastoid, NB4
Transcripts: OTTHUMT00000030686, OTTHUMT00000030687, OTTHUMT00000030688, UC001EBY.1
Position: Human Assembly Chr Position (strand) Source Build 36 1 112,739,566 - 112,740,487 (+) MPROMDB